[1]Levine JM, Reynolds R, Fawcett JW. The oligodendrocyte precursor cell in health and disease[J]. Trends Neurosci, 2001, 24(1): 39-47.
[2] Peters A. A fourth type of neuroglial cell in the adult central nervous system[J]. J Neurocytol, 2004, 33(3): 345-357.
[3]Wang Y, Su Y, Yu G, et al. Reduced oligodendrocyte precursor cell impairs astrocytic development in early life stress[J]. Adv Sci (Weinh), 2021, 8(16): e2101181.
[4] Yu G, Su Y, Guo C, et al. Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model[J]. Mol Psychiatry, 2022, 27(12): 5154-5166.
[5] Bergles DE, Roberts JD, Somogyi P, et al. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus[J]. Nature, 2000, 405(6783): 187-191.
[6] Ge WP, Yang XJ, Zhang Z, et al. Long-term potentiation of neuron-glia synapses mediated by Ca2+-permeable AMPA receptors[J]. Science, 2006, 312(5779): 1533-1537.
[7] Lin SC, Bergles DE. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus[J]. Nat Neurosci, 2004, 7(1): 24-32.
[8] Zhang X, Liu Y, Hong X, et al. NG2 glia-derived GABA release tunes inhibitory synapses and contributes to stress-induced anxiety[J]. Nat Commun, 2021, 12(1): 5740.
[9] Fenno L,Yizhar O,Deisseroth K.The development and application of optogenetics[J]. Annu Rev Neurosci, 2011, 34: 389-412.
[10] Yizhar O, Fenno LE, Davidson TJ, et al. Optogenetics in neural systems[J]. Neuron, 2011, 71(1): 9-34.
[11] Yu C,Cassar IR,Sambangi J,et al.Frequency-specific optogenetic deep brain stimulation of subthalamic nucleus improves parkinsonian motor behaviors[J]. J Neurosci, 2020, 40(22): 4323-4334.
[12] Lin S, Du Y, Xia Y, et al. Advances in optogenetic studies of depressive-like behaviors and underlying neural circuit mechanisms[J]. Front Psychiatry, 2022, 13: 950910.
[13] Andrews JP, Geng J, Voitiuk K, et al. Multimodal evaluation of network activity and optogenetic interventions in human hippocampal slices[J]. Nat Neurosci, 2024, 27(12): 2487-2499.
[14] Geng Y, Li Z, Zhu J, et al. Advances in optogenetics applications for central nervous system injuries[J]. J Neurotrauma, 2023, 40(13-14): 1297-1316.
[15] Tan P, He L, Huang Y, et al. Optophysiology: illuminating cell physiology with optogenetics[J]. Physiol Rev, 2022, 102(3): 1263-1325.
[16] Oh TJ, Fan H, Skeeters SS, et al. Steering molecular activity with optogenetics: recent advances and perspectives[J]. Adv Biol (Weinh), 2021, 5(5): e2000180.
[17] Chen W, Li C, Liang W, et al. The roles of optogenetics and technology in neurobiology: a review[J]. Front Aging Neurosci, 2022, 14: 867863.
[18] Zhang M, Chen T, Lu X, et al. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery[J]. Signal Transduct Target Ther, 2024, 9(1): 88.
[19] Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions[J]. Physiol Rev, 2005, 85(4): 1159-1204.
[20] Kadamur G, Ross EM. Mammalian phospholipase C[J]. Annu Rev Physiol, 2013, 75: 127-154.
[21] Dai R, Yu T, Weng D, et al. A neuropsin-based optogenetic tool for precise control of G(q) signaling[J]. Sci China Life Sci, 2022, 65(7): 1271-1284.
[22] Wang F, Yang YJ, Yang N, et al. Enhancing oligodendrocyte myelination rescues synaptic loss and improves functional recovery after chronic hypoxia[J]. Neuron, 2018, 99(4): 689-701.
[23] Schatteman GC, Morrison-Graham K, Van Koppen A, et al. Regulation and role of PDGF receptor alpha-subunit expression during embryogenesis[J]. Development, 1992, 115(1): 123-131.
[24] Pringle NP, Mudhar HS, Collarini EJ, et al. PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage[J]. Development, 1992, 115(2): 535-551.
[25] Oishi M, Passlick S, Yamazaki Y, et al. Separate optogenetic manipulation of Nerve/glial antigen 2 (NG2) glia and mural cells using the NG2 promoter[J]. Glia, 2023, 71(2): 317-333.